Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

Perella Weinberg sounds out buyers for $1bn+ NMC Health

Sell-side advisors Perella Weinberg are reportedly circulating teasers for in-administration international operator NMC Health's core GCC business with a view to a potential sale in April. We look at the potential for the potential new owners to consolidate the UAE hospital market.

European mid-market deals return but top end still quiet

Middle-market M&A is picking up again across healthcare sub-sectors in Europe, but investors are still reluctant to take the leap on larger assets. We round up where deals are - and aren't happening, and why. There is close to €1.2bn revenue up for grabs in the dentistry sector, nearly €1bn in the psychiatry sector, and around €750m in other outpatient services like ophthalmology and IVF.

Special report: How rationing care in the pandemic is killing the elderly

People over the age of 80 are up to three times more likely to die of a COVID-19 infection in countries using rigid rationing guidelines that can exclude the elderly from intensive care - and sometimes even from hospital. HBI's extensive analysis of death, hospital and ICU data reveals that Sweden has lost eight times more, England seven and the Netherlands six of its elderly population compared to Germany. In a special report, we explore how rationing killed the elderly.

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 

COVID vaccine: Shot in the arm the markets needed?

Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.

Artemis “enters sales process”

Artemis, Germany's second largest ophthalmology chain by revenue, has entered a sales process, HBI hears from multiple sources.

Private equity targeting €1.2bn Mediq

Netherlands-based medicalised homecare provider and pharmaceutical distributor Mediq is for sale, with a potential €1.2bn price tag. With non-binding bids for the pan-European group due in the first week of November, HBI hears that a private equity buyer is almost certain with little interest from strategic parties.

IDH sale could lead to group breakup

UK-based NHS dental specialist IDH, which operates over 600 UK-based clinics as {my}dentist and supplies thousands of dentists with products and equipment through dental supplier DD, is for sale. Could the group could be broken up if the buyer for the whole is not found?

Find Us